During the past decade, Radiation Oncology Associates PC conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 30 clinical trials were completed, i.e. on average, 272.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 14 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Radiation Oncology Associates PC" #1 sponsor was "Radiation Therapy Oncology Group" with 16 trials, followed by "National Cancer Institute (NCI)" with 13 trials sponsored, "Alliance for Clinical Trials in Oncology" with 5 trials sponsored, "NRG Oncology" with 5 trials sponsored and "Gynecologic Oncology Group" with 5 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Radiation Oncology Associates PC" #1 collaborator was "National Cancer Institute (NCI)" with 33 trials as a collaborator, "NRG Oncology" with 24 trials as a collaborator, "Radiation Therapy Oncology Group" with 5 trials as a collaborator, "Canadian Cancer Trials Group" with 3 trials as a collaborator and "Cancer and Leukemia Group B" with 2 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Radiation Oncology Associates PC" are "Prostate Cancer" (6 trials), "Adult Glioblastoma" (3 trials), "Adult Gliosarcoma" (3 trials), "Endometrial Serous Adenocarcinoma" (3 trials) and "Lung Cancer" (3 trials). Many other conditions were trialed in "Radiation Oncology Associates PC" in a lesser frequency.

Most popular intervention types in "Radiation Oncology Associates PC" are "Radiation" (36 trials), "Drug" (35 trials), "Other" (21 trials), "Biological" (11 trials) and "Procedure" (6 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (12 trials), "Paclitaxel" (9 trials), "Intensity-Modulated Radiation Therapy" (8 trials), "Carboplatin" (7 trials) and "Quality-of-Life Assessment" (7 trials). Other intervention names were less common.

The vast majority of trials in "Radiation Oncology Associates PC" are 32 trials for "All" genders, 8 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Radiation Oncology Associates PC". undefined are not yet recruiting, 3 are recruiting, 20 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Radiation Oncology Associates PC, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Radiation Oncology Associates PC, 1 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 29 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".